Keshaviah P
Baxter Clinical Engineering Laboratory, Baxter Healthcare Corporation, Minneapolis, Minnesota.
Kidney Int Suppl. 1993 Feb;40:S28-38.
The historical bases and implications of the urea kinetic and middle molecule approaches to assessing the adequacy of hemodialysis and continuous ambulatory peritoneal dialysis (CAPD) are reviewed in this paper. A critical reappraisal of the findings of the National Cooperative Dialysis Study (NCDS) demonstrates the importance of small solute removal on clinical outcomes of morbidity and mortality in the hemodialysis setting. The applicability of these results to CAPD is examined in the light of differences in transport characteristics of hemodialysis membranes and the peritoneal membrane. It is shown that small solute removal is important even in assessing CAPD adequacy and that past comparisons of hemodialysis and peritoneal membrane transport may have been flawed. The extrapolation of NCDS results to CAPD on the basis of the peak concentration hypothesis is presented along with a review of several longitudinal, cross-sectional, and multicenter studies of CAPD morbidity and mortality.
本文回顾了采用尿素动力学和中分子方法评估血液透析及持续性非卧床腹膜透析(CAPD)充分性的历史依据及影响。对全国合作透析研究(NCDS)结果的批判性重新评估表明,在血液透析环境中,小分子溶质清除对发病率和死亡率等临床结局具有重要意义。鉴于血液透析膜和腹膜的转运特性存在差异,对这些结果在CAPD中的适用性进行了研究。结果表明,即使在评估CAPD充分性时,小分子溶质清除也很重要,而且过去对血液透析和腹膜转运的比较可能存在缺陷。介绍了基于峰值浓度假说将NCDS结果外推至CAPD的情况,并对几项关于CAPD发病率和死亡率的纵向、横断面及多中心研究进行了综述。